Staphylococcus aureus bacteremic pneumonia

C De la Calle1, L Morata2, N Cobos-Trigueros2

  • 1Department of Infectious Diseases Hospital Clínic, Barcelona, Spain. DELACALLE@CLINIC.UB.ES.

Insights

Staphylococcus aureus bacteremic pneumonia is a severe infection with a high mortality rate, often affecting patients with underlying health conditions. This study highlights the persistent high mortality and identifies risk factors for methicillin resistance.

Area of Science:

  • Infectious Diseases
  • Pulmonology
  • Critical Care Medicine

Background:

  • Staphylococcus aureus bacteremic pneumonia is an uncommon but severe condition with scarce published data.
  • High mortality rates underscore the need for updated epidemiological and risk factor analysis.

Purpose of the Study:

  • To identify risk factors associated with methicillin resistance in Staphylococcus aureus bacteremic pneumonia.
  • To update the current mortality rates for this infection.

Main Methods:

  • Prospective collection of patients with S. aureus bacteremic pneumonia from 2000 to 2014.
  • Retrospective analysis to identify risk factors and compare outcomes between methicillin-susceptible (MSSA) and methicillin-resistant (MRSA) strains.

Main Results:

  • A total of 98 patients were included; 40.8% had community-acquired infections.
  • Frequent comorbidities included chronic lung disease, renal failure, diabetes, and cardiovascular disease.
  • Overall 30-day mortality was 46.9%. MRSA infections occurred in older patients with more cardiovascular disease and prior antibiotic exposure.

Conclusions:

  • Staphylococcus aureus bacteremic pneumonia remains a severe infection with high mortality, particularly in patients with comorbidities.
  • While MSSA infections presented with more septic shock, appropriate empirical antibiotic therapy was more common than for MRSA.
  • No significant difference in mortality was observed between MSSA and MRSA infections.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.3K
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
39
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
37
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.2K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
4.1K
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
69